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Abstract A series of new imidazole substituted indeno
[1,2-b]quinoline-9,11-dione derivatives were synthesized
and evaluated for their antiproliferative effects on HeLa,
LS180, MCF-7 and Jurkat human cancer cell lines. Anti-
proliferative effects were evaluated using MTT assay.
Prepared compounds exhibited weak to good antiprolifer-
ative activity in evaluated cell lines. Prepared compounds
were more potent in Jurkat cell line when compared to
LS180, HeLa and MCF-7 cell lines. Compounds 29
(IC16 = 0.7 lM) and 31 (IC16 = 1.7 lM) and 33 (IC16 =
1.7 lM) were found to be the most potent molecules on
Jurkat cell lines. Moreover; it was found that some of the
tested compounds bearing imidazole-2-yl moiety on the
C11-position of dihydropyridine ring exhibited superior
antiproliferative activity in comparison to cis-platin espe-
cially in Jurkat cell line (compounds 29, 31, and 33). It
seemed that the introduction of electron-withdrawing
groups on the imidazole ring enhanced the antiproliferative
potential of these compounds (compounds 27, 29 and 31).
The results of this study proposed that some of the imid-
azole substituted indeno[1,2-b]quinoline-9,11-dione com-
pounds may act as efficient anticancer agents in vitro,
emphasizing their potential role as a source for rational
design of potent antiproliferative agents.
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Introduction
Dihydropyridines (DHPs) are heterocyclic structures that
have found significant attention among researchers. Many
efforts on ruling synthetic routes for DHP scaffolds began
after the first successful synthesis of symmetric 1,4-DHP
derivative via one-pot cyclocondensation reaction of
ammonia with alkylacetoacetate and aldehyde more than a
century ago (Hantzsch 1882). Since then, a variety of
synthetic procedures have been elucidated for preparation
of symmetrical and unsymmetrical DHP derivatives
(Vanden Eynde and Mayence 2003; Saini et al. 2008;
Swarnalatha et al. 2011; Hugel 2009).
Besides synthetic feature, DHPs have been looked upon
as one of the most important medicinal scaffolds possess-
ing interesting biological properties such as anti-hyper-
tensive (Nekooeian et al. 2010; Shafiee et al. 2002),
calcium channel modulating (Miri et al. 2008; Davood
et al. 2006), antituberculosis (Shafii et al. 2008), anti-
coagulant (Kumar et al. 2011), antidyslipidemic (Kumar
et al. 2010), anti-oxidant (Kumar et al. 2010; Leon et al.
2008), and multidrug resistance reversal (MDR) (Tasaka
et al. 2001) activities.
In this regard, several reports indicating anti-tumor
activity of symmetric 3,5-dicarboxamide (Sirisha et al.
2010), 3,5-diketo (Engi et al. 2006; Bazargan et al. 2008),
3,5-dicarboxylate (Engi et al. 2006; Foroughinia et al.
2008) and 3,5-dicyano (Abbas et al. 2010) derivatives of
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